keyword
Keywords Non pharmacologic treatment of...

Non pharmacologic treatment of ADHD

https://read.qxmd.com/read/38610871/a-female-specific-treatment-group-for-adhd-description-of-the-programme-and-qualitative-analysis-of-first-experiences
#1
JOURNAL ARTICLE
M de Jong, D S M R Wynchank, M Michielsen, A T F Beekman, J J S Kooij
Background : The diagnostics and treatment of attention-deficit/hyperactivity disorder (ADHD) in women remain insufficient. Fluctuations of reproductive hormones during the premenstrual period, postpartum period, and (peri)menopause are neglected, even though they impact ADHD symptoms and associated mood disorders. Therefore, we created a female-specific treatment group for women with ADHD and premenstrual worsening of ADHD and/or mood symptoms. Methods : We describe the group programme and underlying rationale, offering a qualitative analysis of the participants' evaluation...
April 4, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38596418/diagnosis-and-treatment-of-adhd-in-the-pediatric-population
#2
JOURNAL ARTICLE
Lea S Eiland, Brooke L Gildon
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood with approximately 6 million children (age 3 to 17 years) ever diagnosed based on data from 2016-2019. ADHD is characterized by a constant pattern of inattention and/or hyperactivity-impulsivity symptoms that interferes with development or functioning. Specific criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th edition Text Revision assist with the diagnosis with multiple guidelines available providing non-pharmacologic and pharmacologic recommendations for the treatment of ADHD in the pediatric population...
April 2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38595455/martial-arts-as-a-tool-for-enhancing-attention-and-executive-function-implications-for-cognitive-behavioral-therapy-a-literature-review
#3
REVIEW
Venkateswar Pujari
With a focus on its implications for cognitive behavioral therapy (CBT), this review study seeks to investigate the possible advantages of martial arts training on attention and executive function. Common cognitive impairments seen in a variety of psychiatric diseases, such as depression and attention deficit hyperactivity disorder, include difficulties in attention and executive function. Training in martial arts, which is known for its demanding physical and mental requirements, has drawn interest as a potential intervention for improving cognitive function...
February 2024: Journal of Pharmacy & Bioallied Sciences
https://read.qxmd.com/read/38594701/effects-of-yoga-on-impulsivity-in-patients-with-and-without-mental-disorders-a-systematic-review
#4
JOURNAL ARTICLE
Yuri de Castro Machado, Mariana Oliveira, Jogiely Larissa Ferreira Lima, Hemant Bhargav, Shivarama Varambally, Débora Marques de Miranda, Marco Aurélio Romano-Silva
BACKGROUND: Yoga can be used as a complementary intervention to conventional treatments, whether pharmacological or non-pharmacological. Sustained practice of yoga can generate a series of benefits for individuals' quality of life and improve their physical fitness. OBJECTIVE: To investigate the potential effects of yoga as an adjunct intervention in conditions involving impulse control issues, such as attention deficit hyperactivity disorder (ADHD), borderline personality disorder, bipolar affective disorder, and substance use disorders...
April 9, 2024: BMC Psychiatry
https://read.qxmd.com/read/38586804/alternative-treatments-to-pharmacological-therapy-in-pediatric-populations-with-attention-deficit-hyperactivity-disorder-adhd-a-scoping-review
#5
REVIEW
Lexie Leon, Tram Tran, Meera Navadia, Janavi Patel, Annelies Vanderveen, Maria I Cruz, Thuy-Mai Le, Freda B Assuah, Victoria Prager, Darshil Patel, Joshua M Costin
In recent years, there has been an increase in the prevalence of the diagnosis of attention-deficit/hyperactivity disorder (ADHD), a cognitive and behavioral disorder in which individuals present with inattention and impulsivity, in the pediatric population. With an increase in diagnoses, there is also increasing concern regarding overdiagnosis and overtreatment with medications for ADHD. The objective of this study was to map out and compile the recent literature pertaining to alternative therapies (e.g., physical activity, diet, mindfulness, and computer-based interventions) for children and adolescents diagnosed with ADHD in an attempt to reduce or replace the use of pharmacological therapy...
March 2024: Curēus
https://read.qxmd.com/read/38577402/the-detect-consensus-report-on-attention-deficit-hyperactivity-disorder-and-its-management-among-turkish-children-and-adolescents-detect-consensus-report-on-adhd-among-turkish-youth
#6
JOURNAL ARTICLE
Hakan Öğütlü, Özlem Meryem Kütük, Ali Evren Tufan, Aynur Pekcanlar Akay, Özlem Yildiz Gündoğdu, Eyüp Sabri Ercan
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most common and heritable neurodevelopmental disorders which may last through the life-span. A consensus report on diagnosis and management of ADHD among Turkish youth was prepared previously. However, the participants as well as the management options were rather limited and developments in the past decade necessitated a revision and update of the consensus. Therefore, this review aims to summarize the consensus among Child and Adolescent Psychiatrists from Türkiye on the nature and management of pediatric ADHD...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38490015/settling-a-distracted-globe-an-overview-of-psychosocial-and-psychotherapeutic-treatment-of-attention-deficit-hyperactivity-disorder
#7
REVIEW
Xenia Gonda, Sara Balint, Janos Miklos Rethelyi, Peter Dome
While the currently prevailing theory of ADHD postulates a neurobiological background and core deficits of behavioural inhibition and executive functioning as the basis of ADHD symptoms, our current conceptualisation also acknowledges the essential contributory role of psychosocial, ecological, and cognitive factors. Considering the multifactorial background of ADHD, its treatment equally needs to be multifactorial involving, besides pharmacotherapy, skill development and psychotherapy as well, especially if we postulate the increasing contribution of social factors in the background of the increasing burden of ADHD...
March 14, 2024: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://read.qxmd.com/read/38467484/modafinil-an-atypical-cns-stimulant
#8
JOURNAL ARTICLE
Melinda Hersey, Gianluigi Tanda
Modafinil is a central nervous system stimulant approved for the treatment of narcolepsy and sleep disorders. Due to its wide range of biochemical actions, modafinil has been explored for other potential therapeutic uses. Indeed, it has shown promise as a therapy for cognitive disfunction resulting from neurologic disorders like ADHD, and as a smart drug in non-medical settings. The mechanism(s) of actions underlying the therapeutic efficacy of this agent remains largely elusive. Modafinil is known to inhibit the dopamine transporter, thus decreasing dopamine reuptake following neuronal release, an effect shared by addictive psychostimulants...
2024: Advances in Pharmacology
https://read.qxmd.com/read/38430553/psychiatric-comorbidities-and-prescribing-tendencies-of-sleep-medications-and-related-medications-in-young-people-with-insomnia-a-united-states-commercial-claims-based-analysis
#9
JOURNAL ARTICLE
Greta Bushnell, Anna Ivanenko, Daniel B Horton, Jessica R Lunsford-Avery, Jonathan Posner, Tobias Gerhard, Elizabeth Suarez, Mark Olfson
STUDY OBJECTIVES: To characterize children and youth newly diagnosed with insomnia and to describe their use of sleep and other related prescription medications. METHODS: Within a commercial claims database (1/1/2016-12/31/2021), we identified children and youth (2-24 years) with a newly recorded insomnia diagnosis (G47.0x;F51.0x) and examined psychiatric diagnoses in the prior 6 months. We evaluated sleep and related prescription medications dispensed in the week after new insomnia diagnoses (i...
March 2, 2024: Sleep
https://read.qxmd.com/read/38418443/adhd-medications-use-and-risk-of-mortality-and-unintentional-injuries-a-population-based-cohort-study
#10
JOURNAL ARTICLE
Helen-Maria Vasiliadis, Carlotta Lunghi, Elham Rahme, Louis Rochette, Martin Gignac, Victoria Massamba, Fatoumata Binta Diallo, Alvine Fansi, Samuele Cortese, Alain Lesage
We assessed the association between the use of medications for attention-deficit/hyperactivity disorder (ADHD) and the risk of all-cause mortality and unintentional injuries leading to emergency department (ED) or hospital admission in individuals aged ≤24 years with ADHD. We conducted a population-based retrospective cohort study between 2000 and 2021 using Quebec health administrative data. Individuals were followed from the first ADHD diagnosis or ADHD medication claim until turning 25, death, or study end...
February 28, 2024: Translational Psychiatry
https://read.qxmd.com/read/38388701/attention-deficit-hyperactivity-disorder
#11
REVIEW
Stephen V Faraone, Mark A Bellgrove, Isabell Brikell, Samuele Cortese, Catharina A Hartman, Chris Hollis, Jeffrey H Newcorn, Alexandra Philipsen, Guilherme V Polanczyk, Katya Rubia, Margaret H Sibley, Jan K Buitelaar
Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genetic aetiology that involves common and rare genetic variants. Some environmental correlates of the disorder have been discovered but causation has been difficult to establish. The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences...
February 22, 2024: Nature Reviews. Disease Primers
https://read.qxmd.com/read/38326137/non-pharmacological-treatment-of-attention-deficit-disorder-with-or-without-hyperactivity-adhd-overview-and-report-of-the-first-international-symposium-on-the-non-pharmacological-management-of-adhd
#12
JOURNAL ARTICLE
Amélie Dentz, Chantal Martin Soelch, Cherine Fahim, Alexandra Torsello, Véronique Parent, Albert Ponsioen, Marie-Claude Guay, Stéphanie Bioulac-Rogier, Céline Clément, Michel Bader, Lucia Romo
Attention Deficit Disorder with or without Hyperactivity (ADHD is a neurodevelopmental disorder which affects the day-to-day functioning of children and adults with this condition. Pharmacological treatment can reduce the symptoms associated with ADHD, but it has some limitations. The objective of this symposium is to determine the effects of non-pharmacological approaches on ADHD symptoms. Results indicate that the following intervention are promising approaches: cognitive behavioral therapy (CBT), mindfulness-based interventions (MBI), yoga, cognitive and metacognitive intervention, neurofeedback and parental training programs...
February 6, 2024: L'Encéphale
https://read.qxmd.com/read/38311473/attention-deficit-hyperactivity-disorder-self-esteem-and-the-impact-of-treatments
#13
JOURNAL ARTICLE
Laurie Sürig, Hala Kerbage, Elodie Courtabessis, Emanuel Diaz, Antoine Visier, Erica Fongaro, Diane Purper-Ouakil
OBJECTIVES: Children with attention deficit hyperactivity disorder (ADHD) experience repetitive failures in their school and social life and often receive negative feedback from their environment, endangering the development of their self-esteem. Self-esteem is a forecasting factor for social, psychological, professional and familial well-being. Poor self-esteem is a risk factor for the development of depression, anxiety disorder, and personality disorder. The aim of this article is to evaluate the child's self-esteem at the initial time of ADHD diagnosis, describe self-esteem evolution after diagnosis and identify clinical and therapeutic factors associated with improved self-esteem...
February 3, 2024: L'Encéphale
https://read.qxmd.com/read/38280943/improving-methylphenidate-titration-in-children-with-attention-deficit-hyperactivity-disorder-adhd-a-randomized-controlled-trial-using-placebo-controlled-titration-implemented-in-clinical-practice
#14
JOURNAL ARTICLE
Karen Vertessen, Marjolein Luman, Pierre Bet, Catharina E Bergwerff, Marco Bottelier, Reino Stoffelsen, James M Swanson, Annemiek Wisse, Jos Twisk, Jaap Oosterlaan
BACKGROUND AND OBJECTIVES: Concerns exist regarding the rising use of methylphenidate. A double-blind, placebo-controlled methylphenidate titration (PCT) for children with attention-deficit/hyperactivity disorder (ADHD) has shown potential to improve titration (i.e., detection of placebo responders and larger ADHD symptom improvement) in experimental settings. This study aims to determine if these advantages can be transferred to clinical settings. METHOD: Children (aged 5-13 years) with an ADHD diagnosis and an indication to start methylphenidate (MPH) treatment were recruited...
January 27, 2024: Paediatric Drugs
https://read.qxmd.com/read/38178649/treating-executive-function-in-youth-with-attention-deficit-hyperactivity-disorder-a-review-of-pharmacological-and-non-pharmacological-interventions
#15
JOURNAL ARTICLE
Timothy E Wilens, Mira Stone, Sylvia Lanni, Amy Berger, Ronan L H Wilson, Melis Lydston, Craig B Surman
INTRODUCTION: Executive function (EF) deficits are common in youth with ADHD and pose significant functional impairments. The extent and effect of interventions addressing EF in youth with ADHD remain unclear. METHODS: We conducted a systematic literature review using PRISMA guidelines. Included studies were randomized controlled trials of interventions to treat EF in youth with ADHD. RESULTS: Our search returned 136 studies representing 11,443 study participants...
January 4, 2024: Journal of Attention Disorders
https://read.qxmd.com/read/38135943/self-regulation-of-attention-in-children-in-a-virtual-classroom-environment-a-feasibility-study
#16
JOURNAL ARTICLE
Carole Guedj, Rémi Tyrand, Emmanuel Badier, Lou Planchamp, Madison Stringer, Myriam Ophelia Zimmermann, Victor Férat, Russia Ha-Vinh Leuchter, Frédéric Grouiller
Attention is a crucial cognitive function that enables us to selectively focus on relevant information from the surrounding world to achieve our goals. Impairments in sustained attention pose challenges, particularly in children with attention deficit hyperactivity disorder, a neurodevelopmental disorder characterized by impulsive and inattentive behavior. While psychostimulant medications are the most effective ADHD treatment, they often yield unwanted side effects, making it crucial to explore non-pharmacological treatments...
November 24, 2023: Bioengineering
https://read.qxmd.com/read/38126038/a-review-of-recent-treatments-for-adults-living-with-attention-deficit-hyperactivity-disorder
#17
REVIEW
Candice Wakelin, Michele Willemse, Erica Munnik
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a neuro-developmental disorder prevalent among children and adults. Adults living with ADHD can experience significant distress affecting their daily functioning on emotional, physical, interpersonal, familial and financial levels. Intervention programmes may be a way to mitigate these challenges. AIM: This review identified good evidence-based intervention studies for adults with ADHD and described the usefulness of these interventions...
2023: South African Journal of Psychiatry: SAJP
https://read.qxmd.com/read/38086595/lisdexamphetamine-versus-methylphenidate-for-paediatric-patients-with-attention-deficit-hyperactivity-disorder-and-type-1-diabetes-lamaindiab-protocol-for-a-multicentre-randomised-cross-over-clinical-trial-in-an-outpatient-telemedicine-supported-setting
#18
JOURNAL ARTICLE
Arkadiusz Michalak, Jędrzej Chrzanowski, Hanna Kuśmierczyk-Kozieł, Ewa Klejman, Katarzyna Błaziak, Beata Mianowska, Agnieszka Szadkowska, Agata P Chobot, Przemysława Jarosz-Chobot, Małgorzata Myśliwiec, Iwona Makowska, Anna Kalenik, Monika Zamarlik, Tomasz Wolańczyk, Wojciech Fendler, Agnieszka Butwicka
INTRODUCTION: Attention deficit hyperactivity disorder (ADHD) affects 5%-10% of paediatric population and is reportedly more common in children with type 1 diabetes (T1D), exacerbating its clinical course. Proper treatment of ADHD in such patients may thus provide neurological and metabolic benefits. To test this, we designed a non-commercial second phase clinical trial comparing the impact of different pharmacological interventions for ADHD in children with T1D. METHODS AND ANALYSIS: This is a multicentre, randomised, open-label, cross-over clinical trial in children and adolescents with ADHD and T1D...
December 12, 2023: BMJ Open
https://read.qxmd.com/read/38070766/executive-control-training-for-adolescents-with-adhd-study-protocol-for-a-randomized-controlled-trial
#19
JOURNAL ARTICLE
Agnete Dyresen, Jan Stubberud, Krister Westlye Fjermestad, Ingvild Haugen, Merete Glenne Øie
BACKGROUND: Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental conditions diagnosed during childhood and adolescence. In addition to the commonly observed symptoms of inattention, hyperactivity, and impulsivity, individuals with ADHD often experience impairments in executive functions (EFs). Goal management training (GMT) is a cognitive remediation intervention targeting EFs, with empirical support from studies with adult populations, including ADHD...
December 7, 2023: Contemporary Clinical Trials
https://read.qxmd.com/read/38016697/time-after-time-failure-to-identify-and-support-females-with-adhd-a-swedish-population-register-study
#20
JOURNAL ARTICLE
Charlotte Skoglund, Inger Sundström Poromaa, Daniel Leksell, Katarina Ekholm Selling, Thomas Cars, Maibritt Giacobini, Susan Young, Helena Kopp Kallner
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is associated with risk taking and negative health-related outcomes across the lifespan. Due to delay in referral and diagnostics, young females with ADHD may not be identified, nor appropriately supported by adequate interventions. METHODS: A total of 85,330 individuals with ADHD, all of whom were residents in Stockholm County between January 01, 2011, and December 31, 2021, were included as participants in this population-based, cross-sectional cohort study...
November 28, 2023: Journal of Child Psychology and Psychiatry, and Allied Disciplines
keyword
keyword
44086
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.